{"server":{"$schema":"https://static.modelcontextprotocol.io/schemas/2025-12-11/server.schema.json","name":"com.midgardfinance/drugs","description":"Obesity and incretin drug trials: weight loss by dose with its estimand, adverse events, catalysts","title":"Midgard Finance drug data","version":"0.1.2","websiteUrl":"https://www.midgardfinance.com/obesity/","remotes":[{"type":"streamable-http","url":"https://mcp.midgardfinance.com/mcp"}]},"_meta":{"io.modelcontextprotocol.registry/official":{"status":"active","statusChangedAt":"2026-10-30T09:21:33.279477Z","publishedAt":"2026-10-30T09:21:33.279477Z","updatedAt":"2026-10-30T09:21:33.279477Z","isLatest":true}}}
